Interferon-? activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-? secretion by immature human natural killer cells
- 1 January 1995
- journal article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 15 (1) , 35-44
- https://doi.org/10.1007/bf01489488
Abstract
Natural killer (NK) cells play an important role in host defense mechanisms against infection and neoplasia. Interferon-α (IFN-α) has been shown to activate NK cells and to augment their cytotoxic activity, albeit its role in the maturation pathway of NK cells has not been elucidated. The present study examined whether IFN-α activates the immature NK subset (Free cells) to become cytotoxic and also ascertained whether IFN-α uses the same pathway of activation as that mediated by interleukin-2 (IL-2). Incubation of sorted Free cells overnight with IFN-α resulted in augmentation of their cytotoxic function against NK sensitive target cells. The enhanced cytotoxic activity was not accompanied by a new recruitment of NK-target binder cells but by an increase in the frequency of killer cells in the conjugate fraction. Activation of the Free subset by IFN-α resulted in upregulation of CD69, CD11b, and CD2 surface expression and stimulated secretion of IFN-γ. Unlike IL-2, IFN-α did not stimulate the Free cells to proliferate or secrete TNF-α and activation of cytotoxicity and modulation of surface antigens by IFN-α were independent of TNF-α. The failure of IFN-α to stimulate secretion and proliferation by Free cells appeared to be mediated by negative signals. This was corroborated in experiments demonstrating that when Free cells were cultured with both IFN-α and IL-2, a significant inhibition was observed for both the IL-2 dependent secretion of TNF-α and proliferation. These results demonstrate that IFN-α serves as both an activator and a regulator of NK function. Further, activation of the immature Free NK cells by IL-2 and IFN-α proceeds by TNF-α-dependent and independent pathways, respectively. The findings also support our contention that the mechanism of activation of the cytotoxic machinery of NK cells is not linked to the mechanism of activation of cytokine secretion and/or proliferation.Keywords
This publication has 24 references indexed in Scilit:
- Pivotal Role of Endogenous TNF-α in the IL-2-Driven Activation and Proliferation of the Functionally Immature NK Free SubsetCellular Immunology, 1993
- Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.The Journal of Experimental Medicine, 1992
- Chemo-Immunotherapy of murine solid tumors: Enhanced therapeutic effects by interleukin-2 combined with interferon α and the role of specific T cellsCancer Immunology, Immunotherapy, 1992
- Letter to the editorInternational Journal of Cancer, 1991
- Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders.The Journal of Experimental Medicine, 1990
- Cyclosporin A inhibition of interleukin 2 gene expression, but not natural killer cell proliferation, after interferon induction in vivo.The Journal of Experimental Medicine, 1990
- The inhibitory effect of human interferon α on the generation of lymphokine-activated killer activityCancer Immunology, Immunotherapy, 1989
- The alternative pathway of T cell activation: Biology, pathophysiology, and perspectives for immunopharmacologyClinical Immunology and Immunopathology, 1989
- Surface molecules involved in CD3-negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cellsInternational Journal of Cancer, 1989
- Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines.The Journal of Experimental Medicine, 1986